| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/24/1998 | US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified |
| 02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
| 02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
| 02/24/1998 | US5721106 Detecting amount of labelled peptide bound to silk; useful in detecting or monitoring alzheimer's disease |
| 02/24/1998 | US5721104 Screening assay for anti-HIV drugs |
| 02/24/1998 | US5721095 HIV-1/HIV-2 viral detection kit and method |
| 02/24/1998 | US5720959 Malaria vaccine |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/24/1998 | US5720955 Method of treating rheumatoid arthritis with soluble collagen |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720952 Administering colony stimulating factor |
| 02/24/1998 | US5720936 Screening compounds for effect on alzheimer*s disease by administering to transgenic mouse bearing nucleic acid construct coding for amyloid precursor protein, determining altered expression or processing of said protein |
| 02/24/1998 | US5720934 Technetium-99M labeled peptides for imaging |
| 02/24/1998 | CA2002208C Extraction methods for preparing thromboplastin reagents |
| 02/24/1998 | CA1339684C Plant ubquitin promoter system |
| 02/24/1998 | CA1339680C Phenylacetylglutamine (pag) analytical test |
| 02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
| 02/23/1998 | CA2183900A1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 02/22/1998 | CA2213057A1 An amide derivative of amythiamicin |
| 02/19/1998 | WO1998007035A1 Assay for quantifying arthritic conditions |
| 02/19/1998 | WO1998007033A1 Improved western blot test for the identification of antibodies specific against the hcmv virus |
| 02/19/1998 | WO1998007032A1 Method and kit for assessing bone resorption |
| 02/19/1998 | WO1998006871A1 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma |
| 02/19/1998 | WO1998006864A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | WO1998006863A1 A vector for polynucleotide vaccines |
| 02/19/1998 | WO1998006861A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 02/19/1998 | WO1998006860A1 Peptide with inhibitory activity towards plant pathogenic fungi |
| 02/19/1998 | WO1998006851A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS) |
| 02/19/1998 | WO1998006850A1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines |
| 02/19/1998 | WO1998006849A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006846A1 Human induced tumor protein |
| 02/19/1998 | WO1998006845A1 Mammalian ribonuclease inhibitors and use thereof |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006843A1 Neuritin, a neurogene |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006840A1 Novel human glycoprotein |
| 02/19/1998 | WO1998006839A1 Cd44-like protein |
| 02/19/1998 | WO1998006838A1 Methods and means for modifying complement activation |
| 02/19/1998 | WO1998006836A2 Expression system derived from the lipase regulation cascade of pseudomonas alcaligenes |
| 02/19/1998 | WO1998006827A2 Method for immortalizing cells |
| 02/19/1998 | WO1998006753A2 P53 mutant |
| 02/19/1998 | WO1998006752A1 A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway |
| 02/19/1998 | WO1998006751A1 Mcp-3, rantes and mip-1alpha receptor antagonists |
| 02/19/1998 | WO1998006750A2 Resistance against nematodes and/or aphids |
| 02/19/1998 | WO1998006749A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | WO1998006748A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | WO1998006747A2 Uses for wnt polypeptides |
| 02/19/1998 | WO1998006737A1 Long wavelength engineered fluorescent proteins |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006435A2 COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
| 02/19/1998 | WO1998006432A1 Outer membrane protein b1 of moraxella catarrhalis |
| 02/19/1998 | WO1998006430A1 Vaccines, antibodies, proteins, glycoproteins, dnas and rnas for prophylaxis and treatment of cryptosporidium parvum infections |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006428A1 Mucosal immunogens for novel vaccines |
| 02/19/1998 | WO1998006424A1 Cancerous metastasis inhibitors for oral administration |
| 02/19/1998 | WO1998006416A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | WO1998006415A2 Anti-chlamydial methods and materials |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006264A1 Plasmin-depletion therapy |
| 02/19/1998 | WO1998006263A1 Programmed cell death and ich-3 |
| 02/19/1998 | WO1998006248A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 02/19/1998 | WO1998002560A3 Genomic sequence of rhizobium sp. ngr 234 symbiotic plasmid |
| 02/19/1998 | WO1998002036A3 Animal model knock-out for a neuronal intermediate filament protein |
| 02/19/1998 | WO1998001469A3 Secreted proteins and polynucleotides encoding them |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | WO1997046587A3 Ob protein binding protein |
| 02/19/1998 | WO1997044451A3 Vasoactive amine binding molecules |
| 02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
| 02/19/1998 | WO1997041155A3 Compositions and methods for isolating lung surfactant hydrophobic proteins sp-b and sp-c |
| 02/19/1998 | WO1997038085A3 Genes amplified in cancer cells |
| 02/19/1998 | WO1997037024A3 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 02/19/1998 | DE19632862A1 Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe Immunologically active proteins of Borrelia burgdorferi, nucleic acids coding therefor and the use thereof in test kits and as vaccines |
| 02/19/1998 | CA2263730A1 Delivery of tolerogenic antigens via edible plants or plant-derived products |
| 02/19/1998 | CA2263706A1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263219A1 Methods and means for modifying complement activation |
| 02/19/1998 | CA2263195A1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 02/19/1998 | CA2263172A1 Two human nsp-like proteins |
| 02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
| 02/19/1998 | CA2263165A1 Human induced tumor protein |
| 02/19/1998 | CA2263146A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2262748A1 Defining epitopes of the outer membrane protein copb of moraxella catarrhalis |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/19/1998 | CA2262507A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2262429A1 Peptide with inhibitory activity towards plant pathogenic fungi |
| 02/19/1998 | CA2262427A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
| 02/19/1998 | CA2262422A1 Programmed cell death and ich-3 |
| 02/18/1998 | EP0824150A2 Plant promoter and utilization thereof |
| 02/18/1998 | EP0824103A1 Method for synthesis of Tyr-3-octreotide |
| 02/18/1998 | EP0823848A1 Tissue adhesive using synthetic cross-linking |
| 02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
| 02/18/1998 | CN1173896A Novel DNAS, novel polypeptides and novel antibodies |
| 02/18/1998 | CN1173877A Novel membrane proteins of helicobacter pylori |